These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6306238)

  • 1. 4-(Aminoalkyl)-7-hydroxy-2(3H)-indolones, a novel class of potent presynaptic dopamine receptor agonists.
    Huffman WF; Hall RF; Grant JA; Wilson JW; Hieble JP; Hahn RA
    J Med Chem; 1983 Jul; 26(7):933-5. PubMed ID: 6306238
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of presynaptic inhibitory actions of various dopamine analogs on sympathetic neurotransmission in mongrel dogs.
    Lokhandwala MF; Buckley JP
    Life Sci; 1977 Feb; 20(3):507-16. PubMed ID: 190513
    [No Abstract]   [Full Text] [Related]  

  • 3. Activation of peripheral dopamine presynaptic receptors lowers blood pressure and heart rate in dogs.
    Taylor AA; Fennell WH; Feldman MB; Brandon TA; Ginos JZ; Mitchell JR
    Hypertension; 1983; 5(2):226-34. PubMed ID: 6826215
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of presynaptic receptors in the cardiovascular actions of N,N-di-n-propyldopamine in the cat and dog.
    Massingham R; Dubocovich ML; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Oct; 314(1):17-28. PubMed ID: 7442823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syntheses and in vitro evaluation of 4-(2-aminoethyl)-2(3H)-indolones and related compounds as peripheral prejunctional dopamine receptor agonists.
    DeMarinis RM; Gallagher G; Hall RF; Franz RG; Webster C; Huffman WF; Schwartz MS; Kaiser C; Ross ST; Wilson JW
    J Med Chem; 1986 Jun; 29(6):939-47. PubMed ID: 3712384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine receptors and the cardiovascular system.
    Clark BJ
    Postgrad Med J; 1981; 57 Suppl 1():45-54. PubMed ID: 6117848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.
    Brown RA; Dixon J; Farmer JB; Hall JC; Humphries RG; Ince F; O'Connor SE; Simpson WT; Smith GW
    Br J Pharmacol; 1985 Jul; 85(3):599-608. PubMed ID: 2862944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of the dopamine depressor response by molindone, a newly introduced neuroleptic.
    Nandal NV; Mane VR; Balsara JJ; Chandorkar AG
    Indian J Physiol Pharmacol; 1980; 24(2):143-7. PubMed ID: 6103868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular and smooth muscle actions of some indolealkylamines.
    Singh KP; Bhandari DS
    Indian J Physiol Pharmacol; 1973; 17(1):31-9. PubMed ID: 4752049
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of dopamine receptor agonists and antagonists at peripheral neuronal and vascular dopamine receptors in the anaesthetised cat.
    Dallas S; Drew GM; Hilditch A
    J Cardiovasc Pharmacol; 1986; 8(1):116-25. PubMed ID: 2419673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of L-dopa on peripheral sympathetic nerve function: role of presynaptic dopamine receptors.
    Lokhandwala MF; Buckley JP
    J Pharmacol Exp Ther; 1978 Feb; 204(2):362-71. PubMed ID: 621670
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition by 5,6-dihydroxy-2-dimethylaminotetralin (M7) of noradrenergic neurotransmission in the rabbit hypothalamus: role of alpha-2 adrenoceptors and of dopamine receptors.
    Galzin AM; Langer SZ
    J Pharmacol Exp Ther; 1985 May; 233(2):459-65. PubMed ID: 2987485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the cardiovascular actions of dopamine and epinine in the dog.
    Itoh H; Kohli JD; Rajfer SI; Goldberg LI
    J Pharmacol Exp Ther; 1985 Apr; 233(1):87-93. PubMed ID: 2858584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FPL 63012AR: a potent D1-receptor agonist.
    Smith GW; Farmer JB; Ince F; Matu K; Mitchell PD; Naya I; Springthorpe B
    Br J Pharmacol; 1990 Jun; 100(2):295-300. PubMed ID: 1974159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presynaptic modulation of synaptic transmission in Helix pomatia: the effects of serotonin and dopamine antagonists.
    Juel C
    Neuropharmacology; 1981 Apr; 20(4):323-6. PubMed ID: 6117031
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuronal dopamine receptors on autonomic ganglia and sympathetic nerves and dopamine receptors in the gastrointestinal system.
    Willems JL; Buylaert WA; Lefebvre RA; Bogaert MG
    Pharmacol Rev; 1985 Jun; 37(2):165-216. PubMed ID: 2996038
    [No Abstract]   [Full Text] [Related]  

  • 17. Separate serotonin and dopamine receptors modulate the duration of post-tetanic potentiation at an Aplysia synapse without affecting other aspects of synaptic transmission.
    Newlin SA; Schlapfer WT; Barondes SH
    Brain Res; 1980 Jan; 181(1):89-106. PubMed ID: 6243226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and chronic cardiovascular effects of 6-hydroxydopamine in dogs.
    Gauthier P; Nadeau R; De Champlain J
    Circ Res; 1972 Aug; 31(2):207-17. PubMed ID: 4340389
    [No Abstract]   [Full Text] [Related]  

  • 19. Preparation and biological actions of N-2,2,2-trifluoroethyl-2-(3,4-dihydroxyphenyl)ethylamine.
    O'Donnell JP; Azzaro AJ; Urquilla PR
    J Pharm Sci; 1980 Feb; 69(2):149-52. PubMed ID: 7359313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TL-350, an ergoline derivative with dopamine receptor agonist properties.
    Ilhan M; Long JP; Bhatnagar R; Flynn J; Cannon JG; Lee T
    J Pharmacol Exp Ther; 1984 Oct; 231(1):56-60. PubMed ID: 6548524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.